73) Woo KJ, Jeong YJ, Inoue H, Park JW, Kwon TK. Chrysin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression through the inhibition of nuclear factor for IL-6 (NF-IL6) DNA-binding activity. FEBS Lett. 579, 705-711 (2005)

74) Cherukuri DP, Goulet AC, Inoue H, and Nelson MA: Selenomethionine Regulates Cyclooxygenase-2 (COX-2) Expression Through Nuclear Factor-Kappa B (NF-kB) in Colon Cancer Cells. Cancer Biol. Ther. 4, 175-180 (2005)

75) Jing Chen, Min Zhao, Reena Rao, Hiroyasu Inoue, and Chuan-Ming Hao C/EBPbeta and its binding element are required for NFkappaB induced COX2 expression following hypertonic stress J. Biol. Chem. 280, 16354-16359 (2005)　　→　Link

76) Wu CY, Wang CJ, Tseng CC, Chen HP, Wu MS, Lin JT, Inoue H, Chen GH Helicobacter pylori promote gastric cancer cells invasion through a NF-kappaB and COX-2-mediated pathway World J Gastroenterol. 11, 3197-3203 (2005)

77) Yokota C, Kuge Y, Inoue H, Tamaki N, Minematsu K. Bilateral induction of the S-100A9 gene in response to spreading depression is modulated by the cyclooxygenase-2 activity. J Neurol Sci. 2005 234, 11-16 (2005)

78) Park SW, Sung MW, Heo DS, Inoue H, Shim SH, Kim KH. Nitric oxide upregulates the cyclooxygenase-2 expression through the cAMP-response element in its promoter in several cancer cell lines. Oncogene 24, 6689-6698 (2005)

79) Marwaha V, Chen YH, Helms E, Arad S, Inoue H, Bord E, Kishore R, Der Sarkissian R, Gilchrest BA, Goukassian DA. T-oligo treatment decreases constitutive and UVB-induced COX-2 levels through P53-and NFB-dependent repression of the COX-2 promoter. J Biol Chem. 280, 32379-32388 (2005)　　→　Link

80) Komatsu K, Buchanan FG, Katkuri S, Morrow JD, Inoue H, Otaka M, Watanabe S, Dubois RN. Oncogenic Potential of MEK1 in Rat Intestinal Epithelial Cells Is Mediated via Cyclooxygenase-2. Gastroenterology 129, 577-590 (2005)

81) Lim WC, Park M, Bahn JJ, Inoue H, Lee YJ. Hypertonic sodium chloride induction of cyclooxygenase-2 occurs independently of NF-kappaB and is inhibited by the glucocorticoid receptor in A549 cells. FEBS Lett. 579, 6279-6287 (2005)

82) Okawa T, Naomoto Y, Nobuhisa T, Takaoka M, Motoki T, Shirakawa Y, Yamatsuji T, Inoue H, Ouchida M, Gunduz M, Nakajima M, Tanaka N. Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2. Clin Cancer Res. 11, 7995-8005. (2005)　　→　Link

83) Na HK, Inoue H, Surh YJ. ET-18-O-CH3-induced apoptosis is causally linked to COX-2 upregulation in H-ras transformed human breast epithelial cells. FEBS Lett. 579, 6279-6287 (2005)

84) Park W, Lim W, Cho J, Inoue H, Rhyu MR, Lee Y. Inhibitory effects of ginsenoside-Rb1 on activation of the 12-O-tetradecanoylphorbol 13-acetate-induced cyclooxygenase-2 promoter. Planta Med. Feb;72(3):272-275 (2006)　　→　Link

85) Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, Thomas LS, Xu R, Inoue H, Arditi M, Dannenberg AJ, Abreu MT. Cox-2 Is Regulated by Toll-Like Receptor-4 (TLR4) Signaling: Role in Proliferation and Apoptosis in the Intestine. Gastroenterology 131, 862-877 (2006)

86) Callegari E, Norata GD, Inoue H, Catapano AL. Oxidized-HDL3 modulates the expression of Cox-2 in human endothelial cells. Int J Mol Med. 18, 209-213 (2006)

87) S. Takahashi, H. Ogasawara, T. Watanabe, M. Kumagai, H. Inoue, K. Hori Refolding and activation of human prorenin expressed in Escherichia coli: Application of recombinant human rennin for inhibitor screening. Biosci. Biotechnol. Biochem. 70, 2913-2918 (2006)　　→　Link

88) Shibata N, Jishage K, Arita M, Watanabe M, Kawase Y, Nishikawa K, Natori Y, Inoue H, Shimano H, Yamada N, Tsujimoto M, Arai H. Regulation of hepatic cholesterol synthesis by a novel protein (SPF) that accelerates cholesterol biosynthesis. FASEB J. 20, 2642-2644. (2006)　　→　Link